Drug Combo Prolongs Survival in Acute Myeloid Leukemia

THURSDAY, Aug. 13, 2020 -- Overall survival is longer and the incidence of remission is higher among previously untreated, older patients with acute myeloid leukemia (AML) who receive azacitidine plus venetoclax versus azacitidine alone, according...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news